Carlyle Group makes $4.15B offer for J&J business

Published on NewsOK Modified: January 16, 2014 at 1:36 pm •  Published: January 16, 2014
Advertisement
;

TRENTON, N.J. (AP) — Johnson & Johnson said Thursday that it's been offered $4.15 billion by The Carlyle Group for its Ortho-Clinical Diagnostics business, a year after J&J began reviewing strategic options for the blood-testing unit as part of a routine pruning of its extensive family of businesses.

J&J, based in New Brunswick, N.J., has until March 31 to decide whether to accept the offer. Johnson & Johnson executives plan to discuss the offer Tuesday, when the health giant and consumer products company reports fourth-quarter results. The company said Thursday that it will consult with works councils and trade unions representing the unit's employees before making a decision.

The Ortho-Clinical business serves hospitals, testing laboratories and blood banks.

One division supplies equipment and chemicals to screen donated blood for HIV, hepatitis C and other serious diseases, and for typing donated blood to ensure patients get safe, compatible blood transfusions. The other division makes technology for advanced testing of blood to diagnose a range of health conditions and to monitor the effects of medication.

Established in 1937, Ortho Clinical Diagnostics is based in Raritan, N.J., and has factories in Rochester, N.Y.; Pompano Beach, Fla., and Pencoed, Wales. It has more than 4,500 employees and operates in more than 30 countries worldwide.



Trending Now


AROUND THE WEB

  1. 1
    Baylor's Shawn Oakman not impressed by OU's win over Alabama in Sugar Bowl
  2. 2
    Dez Bryant, three Sooners in NFL trade value top 50 (so far)
  3. 3
    Johnny Manziel's No. 2 leads NFL in jersey sales
  4. 4
    You're more likely to get a raise now
  5. 5
    Google has a plan to speed up the Web
+ show more